EI- Nile Co. for Pharmaceuticals and Chemical Industries (EGX:NIPH)

Market Cap	9.25B +528.4%
Revenue (ttm)	2.24B +113.8%
Net Income	240.13M +159.6%
EPS	4.80 +55.8%
Shares Out	50.00M
PE Ratio	38.50
Forward PE	n/a
Dividend	2.00 (1.08%)
Ex-Dividend Date	Oct 29, 2025

Volume	1,466,431
Open	184.90
Previous Close	184.90
Day's Range	186.30 - 194.90
52-Week Range	41.30 - 192.00
Beta	0.67
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 9, 2026

About EGX:NIPH

EI- Nile Co. for Pharmaceuticals and Chemical Industries develops, produces, and sells pharmaceutical products in Egypt. The company offers manufacturing, research and development, training, and biotechnology solutions. It also exports its products to the countries in the Middle East. The company was founded in 1962 and is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 2,500
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: NIPH

Financial Performance

In fiscal year 2025, EGX:NIPH's revenue was 1.29 billion, an increase of 12.86% compared to the previous year's 1.14 billion. Earnings were 125.73 million, an increase of 39.35%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 15, 2026

Data Sources Report a data error